ArticleJournal of Cancer2013

CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo.

Joel G Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.